Cosmo Bio Company,Limited (TYO:3386)

Market Cap	6.95B +5.2%
Revenue (ttm)	11.00B +8.0%
Net Income	347.00M +42.2%
EPS	61.11 +44.9%
Shares Out	5.67M
PE Ratio	20.04
Forward PE	n/a
Dividend	50.00 (4.10%)
Ex-Dividend Date	Jun 29, 2026

Volume	2,900
Open	1,212.00
Previous Close	1,219.00
Day's Range	1,212.00 - 1,230.00
52-Week Range	1,083.00 - 1,486.00
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Cosmo Bio Company,Limited

Cosmo Bio Company,Limited, together with its subsidiaries, operates as a life science trading company worldwide. It is involved in the import, export, manufacture, marketing, sales, and customer support of life science research bio tools, such as reagents, kits, instruments, and software. The company also distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1978
• Employees: 182
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 3386

Financial Performance

In 2025, Cosmo Bio Company,Limited's revenue was 10.77 billion, an increase of 7.26% compared to the previous year's 10.04 billion. Earnings were 337.00 million, an increase of 28.63%.